GlassScriptPhysician profile
Timothy S Thomason
NPI 1114942018
$3,332.31
in general payments reported to CMS, 2019-2025
27 companies · $430 in 2025
The $430 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,089 · 2020: $173 · 2021: $269 · 2022: $303 · 2023: $660 · 2024: $409 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,465 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,465.04 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Med-El Corporation | $747.82 | 2019-2023 | Bci 602 Kit |
| Genzyme Corporation | $570.44 | 2021-2025 | |
| Inspire Medical Systems, INC. | $342.80 | 2023-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $333.17 | 2021-2025 | Dupixent |
| Stryker Corporation | $303.99 | 2019-2022 | |
| Glaxosmithkline, LLC. | $172.32 | 2023-2025 | Nucala |
| Acclarent, INC | $159.21 | 2019-2020 | |
| Alk-Abello, INC | $104.29 | 2020-2022 | |
| Optinose US, INC. | $74.48 | 2019-2025 | |
| Kaleo, INC. | $70.67 | 2021-2022 | |
| Medtronic, INC. | $66.82 | 2024 | Propel |
| Hikma Pharmaceuticals USA | $54.27 | 2022-2024 | Ryaltris |
| Aerin Medical INC. | $35.87 | 2020-2022 | |
| Karl Storz Endoscopy-America | $34.06 | 2025 | |
| Amgen INC. | $34.00 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $30.89 | 2025 | Tezspire |
| Takeda Pharmaceuticals U.S.A., INC. | $28.90 | 2023 | Cuvitru |
| Intersect Ent, INC. | $27.37 | 2019 | |
| Novartis Pharmaceuticals Corporation | $22.11 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $21.82 | 2025 | Exparel |
| Janssen Pharmaceuticals, INC | $18.42 | 2019 | |
| Hologic Sales and Service, LLC | $14.71 | 2024 | Coolseal Generator |
| Phadia US INC. | $13.75 | 2021 | |
| Merck Sharp & Dohme LLC | $13.72 | 2021 | |
| Shire North American Group INC | $13.32 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.72 | 2019 | |
| Olympus America INC. | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Thomason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.